Clinical Trials Directory

Trials / Conditions / Male Contraception

Male Contraception

11 registered clinical trials studyying Male Contraception — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingEffects of NLS-133, a Potential Non-Hormonal "On-Demand" Male Contraceptive
NCT07393334
Next Life SciencesPhase 2
RecruitingOpen Label, Dose Escalation, Repeat Dose Study Evaluating YCT-529 in Healthy Males
NCT06542237
YourChoice Therapeutics, Inc.Phase 1 / Phase 2
CompletedFirst in Human Study Evaluating Single Ascending Oral Doses of YCT-529 in Healthy Males
NCT06094283
YourChoice Therapeutics, Inc.Phase 1
CompletedA First in Human Study, Evaluating the Safety and Efficacy of ADAM™ 1.0
NCT05134428
Contraline, IncN/A
CompletedStudy of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception
NCT03452111
Premier ResearchPhase 2
CompletedStudy of Spermatogenesis Suppression With DMAU Alone or With LNG Versus Placebo Alone in Normal Men
NCT03455075
Premier ResearchPhase 2
Unknown28-Day Repeat-Dose, Dose Escalation Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healt
NCT03298373
Premier ResearchPhase 1
CompletedInjectable DMAU for Male Contraception in Healthy Male Volunteers (CCN015)
NCT02927210
Kimberly MyerPhase 1
CompletedStudy of Serum Testosterone and Nestorone in Females After Secondary Exposure to Nestorone ® (NES) + Testoster
NCT02994602
Kimberly MyerPhase 1
CompletedSingle Dose, Dose-Ranging Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men
NCT02754687
Premier ResearchPhase 1
CompletedPhase 1 Study of Dimethandrolone Undecanoate in Healthy Men
NCT01382069
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterPhase 1